Search

everythinglearnresearchcommunity

for

Search:↓

Women with androgenetic alopecia often have other symptoms of high androgen levels, requiring further hormone testing.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Mohamed Kandil suggests renaming Polycystic Ovary Syndrome to "Polyfollicular Anovulatory Androgenic Syndrome" to better describe its symptoms, but concerns exist that it may not cover all related issues like obesity and depression.

A rare ovarian tumor caused high testosterone and excess hair in a woman, which was resolved after tumor removal.

PCOS symptoms vary by age, affecting diagnosis and treatment.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Women with pituitary adenomas often have reproductive issues, like irregular periods and trouble getting pregnant, but not always breast milk production without pregnancy.

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.

Omega-6 fats in certain cells boost male hormone production.

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.

Stopping the drug usually helps, but tamoxifen or surgery may be needed if symptoms persist.

Genetic response to androgens is key in female pattern baldness, not SHBG levels.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Fibrosis in the bulge area of hair follicles can cause hair thinning in male pattern baldness, and drugs that inhibit fibrosis might help reverse this.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.

A boy's early puberty caused by a testicular tumor returned to normal after surgery.

Menopause affects skin and hair, and more research is needed for effective treatments.

Estradiol gel can cause hair loss in dogs.

Women with prediabetes may have a higher risk of PCOS-like changes, especially if they have impaired glucose tolerance.

CircAGK affects cell death in hair cells by controlling the miR-3180-5p/BAX pathway, which can lead to hair loss.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

Oestrogens are key for bone growth during puberty in both boys and girls.

A new treatment plan for hair loss combines targeted therapies and regenerative strategies to stabilize, reverse, and maintain hair growth.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

Hormone therapy might help improve women's appearance as they age.